Oral Peptide Therapeutics – Technologies have been honed to overcome many of the challenges of administering peptide therapeutics orally, but obstacles remain before drug developers can fully realize the vast potential.
Numerous technologies are currently in development that are designed to enable the oral delivery of peptides. Though each has its unique set of properties and capabilities, all must overcome key obstacles to successfully deliver peptides via the oral route.
This week’s available download is titled “Novel Approaches for Enhancing the Oral Bioavailability & Absorption of Peptides” from Rebecca Nofsinger at Merck. This presentation discusses peptide advantages and challenges, permeation enhancers and models to evaluate permeation limitations in oral absorption.
Scroll through the presentation below….
Interested to gain access to additional novel peptide development strategies while working remotely?
Check out Curtis & Coulter’s Virtual Drug Product Development Content Toolkit
While you are working remotely, we can help you keep up-to-date with the advancing drug product development landscape, by providing you and your team access to innovative drug development strategies and approaches from the comfort of working from home. Stay in the know and relevent with 3 year’s worth (115+) leading industry presentations and case studies from our popular:
- Controlled & Modified Drug Release Summits
- Peptide Drug Design & Delivery Summits
- Global Drug Bioavailability Enhancement Summits
Additionally, open the door to connecting digitally with our previous drug product development participants and innovators instantly, as well as explore opportunities to share your digital content and technology to our wider audience. Whether you are a pharma/biotech company looking for new relevant drug product development content, or a consultant/solution provider looking to network we have a digital remote working solution for you! Click below to find out more.